The U.S. Supreme Court justices today said they will hear a challenge to Myriad Genetics Inc.’s patents on genetic material used in tests for breast and ovarian cancer. Photographer: Chip Somodevilla/Getty Images
The U.S. Supreme Court justices today said they will hear a challenge to Myriad Genetics Inc.’s patents on genetic material used in tests for breast and ovarian cancer. Photographer: Chip Somodevilla/Getty Images
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=622324807&utmp=%2Fphoto%2F2012-11-30%2Fgene-patents-draw-high-court-review-in-biotechnology-test&utmhn=10.248.179.14&utmac=UA-11413116-12&utmhid=173042203)